Loading…
Adenosine and Adenosine Receptors in the Cardiovascular System: Biochemistry, Physiology, and Pharmacology
Cardiomyocytes and vascular cells readily form, transport, and metabolize the endogenous adenine nucleoside adenosine and act to regulate both interstitial and plasma adenosine concentrations. Cardiovascular cells also have membrane adenosine receptors. Cell and tissue distributions, signal transduc...
Saved in:
Published in: | The American journal of cardiology 1997-06, Vol.79 (12), p.2-10 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c562t-db952a159c3420c2078110015d0c9ae9baa1ca441f1923045268d191f24fefe83 |
---|---|
cites | cdi_FETCH-LOGICAL-c562t-db952a159c3420c2078110015d0c9ae9baa1ca441f1923045268d191f24fefe83 |
container_end_page | 10 |
container_issue | 12 |
container_start_page | 2 |
container_title | The American journal of cardiology |
container_volume | 79 |
creator | Shryock, John C Belardinelli, Luiz |
description | Cardiomyocytes and vascular cells readily form, transport, and metabolize the endogenous adenine nucleoside adenosine and act to regulate both interstitial and plasma adenosine concentrations. Cardiovascular cells also have membrane adenosine receptors. Cell and tissue distributions, signal transduction pathways, and pharmacology of each of the four subtypes of adenosine receptors are subjects of intense investigation. The A1-adenosine receptors mediate the negative dromotropic, chronotropic, inotropic, and the anti-β-adrenergic actions of adenosine. Activation of A2A- and perhaps A2B-adenosine receptors causes vasodilation. Evidence of novel actions mediated by A2B- and A3-adenosine receptors is accumulating. Adenosine is cardioprotective during episodes of cardiac hypoxia/ischemia; several potential mechanisms may be involved. Pharmacologic tools are currently available for laboratory investigation of the actions of adenosine, and the development of adenosine receptor subtype-selective agonists and antagonists for therapeutic purposes is beginning. |
doi_str_mv | 10.1016/S0002-9149(97)00256-7 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79130444</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002914997002567</els_id><sourcerecordid>79130444</sourcerecordid><originalsourceid>FETCH-LOGICAL-c562t-db952a159c3420c2078110015d0c9ae9baa1ca441f1923045268d191f24fefe83</originalsourceid><addsrcrecordid>eNqFkV-L1DAUxYMo67j6ERaKiihYzU2TpvFF1sF_sODi6nPIJLdOhraZTdqF-famM8MIgviUm9zfPZzcQ8gF0DdAoX57QyllpQKuXir5KteiLuU9soBGqhIUVPfJ4oQ8JI9S2uQrgKjPyJlirKpEvSCbS4dDSH7Awgyu-HP7jha3Y4ip8EMxrrFYmuh8uDPJTp2Jxc0ujdi_Kz74YNfY-zTG3evier1LPnThV65nveu1ib2x-5fH5EFruoRPjuc5-fnp44_ll_Lq2-evy8ur0oqajaVbKcEMCGUrzqhlVDYA2bhw1CqDamUMWMM5tKBYRblgdePyf1vGW2yxqc7Ji4PuNobbCdOoszuLXWcGDFPSMu-Gcs4z-PQvcBOmOGRvOgtXogI1qz37FwSsrmnDlZqlxIGyMaQUsdXb6HsTdxqonuPS-7j0nIVWUu_j0jLPXRzVp1WP7jR1zCf3nx_7ee-ma6MZrE8njEmpFJtNvj9gmPd65zHqZD0OFp2PaEftgv-Pkd9kd6_F</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1266084994</pqid></control><display><type>article</type><title>Adenosine and Adenosine Receptors in the Cardiovascular System: Biochemistry, Physiology, and Pharmacology</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Shryock, John C ; Belardinelli, Luiz</creator><creatorcontrib>Shryock, John C ; Belardinelli, Luiz</creatorcontrib><description>Cardiomyocytes and vascular cells readily form, transport, and metabolize the endogenous adenine nucleoside adenosine and act to regulate both interstitial and plasma adenosine concentrations. Cardiovascular cells also have membrane adenosine receptors. Cell and tissue distributions, signal transduction pathways, and pharmacology of each of the four subtypes of adenosine receptors are subjects of intense investigation. The A1-adenosine receptors mediate the negative dromotropic, chronotropic, inotropic, and the anti-β-adrenergic actions of adenosine. Activation of A2A- and perhaps A2B-adenosine receptors causes vasodilation. Evidence of novel actions mediated by A2B- and A3-adenosine receptors is accumulating. Adenosine is cardioprotective during episodes of cardiac hypoxia/ischemia; several potential mechanisms may be involved. Pharmacologic tools are currently available for laboratory investigation of the actions of adenosine, and the development of adenosine receptor subtype-selective agonists and antagonists for therapeutic purposes is beginning.</description><identifier>ISSN: 0002-9149</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/S0002-9149(97)00256-7</identifier><identifier>PMID: 9223356</identifier><identifier>CODEN: AJCDAG</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adenosine - metabolism ; Adenosine - pharmacology ; Animals ; Biochemistry ; Biological and medical sciences ; Cardiomyocytes ; Cardiovascular Agents - pharmacology ; Cellular biology ; Circulatory system ; Endothelium ; Fundamental and applied biological sciences. Psychology ; Heart ; Heart - drug effects ; Homocysteine ; Humans ; Hypoxia ; Ischemia ; Medical research ; Myocardium - metabolism ; Proteins ; Receptors, Purinergic P1 - metabolism ; Vertebrates: cardiovascular system</subject><ispartof>The American journal of cardiology, 1997-06, Vol.79 (12), p.2-10</ispartof><rights>1997 Elsevier Science Inc.</rights><rights>1997 INIST-CNRS</rights><rights>Copyright Elsevier Sequoia S.A. Jun 19, 1997</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c562t-db952a159c3420c2078110015d0c9ae9baa1ca441f1923045268d191f24fefe83</citedby><cites>FETCH-LOGICAL-c562t-db952a159c3420c2078110015d0c9ae9baa1ca441f1923045268d191f24fefe83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>309,310,314,776,780,785,786,23911,23912,25120,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2779928$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9223356$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shryock, John C</creatorcontrib><creatorcontrib>Belardinelli, Luiz</creatorcontrib><title>Adenosine and Adenosine Receptors in the Cardiovascular System: Biochemistry, Physiology, and Pharmacology</title><title>The American journal of cardiology</title><addtitle>Am J Cardiol</addtitle><description>Cardiomyocytes and vascular cells readily form, transport, and metabolize the endogenous adenine nucleoside adenosine and act to regulate both interstitial and plasma adenosine concentrations. Cardiovascular cells also have membrane adenosine receptors. Cell and tissue distributions, signal transduction pathways, and pharmacology of each of the four subtypes of adenosine receptors are subjects of intense investigation. The A1-adenosine receptors mediate the negative dromotropic, chronotropic, inotropic, and the anti-β-adrenergic actions of adenosine. Activation of A2A- and perhaps A2B-adenosine receptors causes vasodilation. Evidence of novel actions mediated by A2B- and A3-adenosine receptors is accumulating. Adenosine is cardioprotective during episodes of cardiac hypoxia/ischemia; several potential mechanisms may be involved. Pharmacologic tools are currently available for laboratory investigation of the actions of adenosine, and the development of adenosine receptor subtype-selective agonists and antagonists for therapeutic purposes is beginning.</description><subject>Adenosine - metabolism</subject><subject>Adenosine - pharmacology</subject><subject>Animals</subject><subject>Biochemistry</subject><subject>Biological and medical sciences</subject><subject>Cardiomyocytes</subject><subject>Cardiovascular Agents - pharmacology</subject><subject>Cellular biology</subject><subject>Circulatory system</subject><subject>Endothelium</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Heart</subject><subject>Heart - drug effects</subject><subject>Homocysteine</subject><subject>Humans</subject><subject>Hypoxia</subject><subject>Ischemia</subject><subject>Medical research</subject><subject>Myocardium - metabolism</subject><subject>Proteins</subject><subject>Receptors, Purinergic P1 - metabolism</subject><subject>Vertebrates: cardiovascular system</subject><issn>0002-9149</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><recordid>eNqFkV-L1DAUxYMo67j6ERaKiihYzU2TpvFF1sF_sODi6nPIJLdOhraZTdqF-famM8MIgviUm9zfPZzcQ8gF0DdAoX57QyllpQKuXir5KteiLuU9soBGqhIUVPfJ4oQ8JI9S2uQrgKjPyJlirKpEvSCbS4dDSH7Awgyu-HP7jha3Y4ip8EMxrrFYmuh8uDPJTp2Jxc0ujdi_Kz74YNfY-zTG3evier1LPnThV65nveu1ib2x-5fH5EFruoRPjuc5-fnp44_ll_Lq2-evy8ur0oqajaVbKcEMCGUrzqhlVDYA2bhw1CqDamUMWMM5tKBYRblgdePyf1vGW2yxqc7Ji4PuNobbCdOoszuLXWcGDFPSMu-Gcs4z-PQvcBOmOGRvOgtXogI1qz37FwSsrmnDlZqlxIGyMaQUsdXb6HsTdxqonuPS-7j0nIVWUu_j0jLPXRzVp1WP7jR1zCf3nx_7ee-ma6MZrE8njEmpFJtNvj9gmPd65zHqZD0OFp2PaEftgv-Pkd9kd6_F</recordid><startdate>19970619</startdate><enddate>19970619</enddate><creator>Shryock, John C</creator><creator>Belardinelli, Luiz</creator><general>Elsevier Inc</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7Z</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>19970619</creationdate><title>Adenosine and Adenosine Receptors in the Cardiovascular System: Biochemistry, Physiology, and Pharmacology</title><author>Shryock, John C ; Belardinelli, Luiz</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c562t-db952a159c3420c2078110015d0c9ae9baa1ca441f1923045268d191f24fefe83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Adenosine - metabolism</topic><topic>Adenosine - pharmacology</topic><topic>Animals</topic><topic>Biochemistry</topic><topic>Biological and medical sciences</topic><topic>Cardiomyocytes</topic><topic>Cardiovascular Agents - pharmacology</topic><topic>Cellular biology</topic><topic>Circulatory system</topic><topic>Endothelium</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Heart</topic><topic>Heart - drug effects</topic><topic>Homocysteine</topic><topic>Humans</topic><topic>Hypoxia</topic><topic>Ischemia</topic><topic>Medical research</topic><topic>Myocardium - metabolism</topic><topic>Proteins</topic><topic>Receptors, Purinergic P1 - metabolism</topic><topic>Vertebrates: cardiovascular system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shryock, John C</creatorcontrib><creatorcontrib>Belardinelli, Luiz</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Physical Education Index</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Biochemistry Abstracts 1</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shryock, John C</au><au>Belardinelli, Luiz</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Adenosine and Adenosine Receptors in the Cardiovascular System: Biochemistry, Physiology, and Pharmacology</atitle><jtitle>The American journal of cardiology</jtitle><addtitle>Am J Cardiol</addtitle><date>1997-06-19</date><risdate>1997</risdate><volume>79</volume><issue>12</issue><spage>2</spage><epage>10</epage><pages>2-10</pages><issn>0002-9149</issn><eissn>1879-1913</eissn><coden>AJCDAG</coden><abstract>Cardiomyocytes and vascular cells readily form, transport, and metabolize the endogenous adenine nucleoside adenosine and act to regulate both interstitial and plasma adenosine concentrations. Cardiovascular cells also have membrane adenosine receptors. Cell and tissue distributions, signal transduction pathways, and pharmacology of each of the four subtypes of adenosine receptors are subjects of intense investigation. The A1-adenosine receptors mediate the negative dromotropic, chronotropic, inotropic, and the anti-β-adrenergic actions of adenosine. Activation of A2A- and perhaps A2B-adenosine receptors causes vasodilation. Evidence of novel actions mediated by A2B- and A3-adenosine receptors is accumulating. Adenosine is cardioprotective during episodes of cardiac hypoxia/ischemia; several potential mechanisms may be involved. Pharmacologic tools are currently available for laboratory investigation of the actions of adenosine, and the development of adenosine receptor subtype-selective agonists and antagonists for therapeutic purposes is beginning.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>9223356</pmid><doi>10.1016/S0002-9149(97)00256-7</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0002-9149 |
ispartof | The American journal of cardiology, 1997-06, Vol.79 (12), p.2-10 |
issn | 0002-9149 1879-1913 |
language | eng |
recordid | cdi_proquest_miscellaneous_79130444 |
source | ScienceDirect Freedom Collection 2022-2024 |
subjects | Adenosine - metabolism Adenosine - pharmacology Animals Biochemistry Biological and medical sciences Cardiomyocytes Cardiovascular Agents - pharmacology Cellular biology Circulatory system Endothelium Fundamental and applied biological sciences. Psychology Heart Heart - drug effects Homocysteine Humans Hypoxia Ischemia Medical research Myocardium - metabolism Proteins Receptors, Purinergic P1 - metabolism Vertebrates: cardiovascular system |
title | Adenosine and Adenosine Receptors in the Cardiovascular System: Biochemistry, Physiology, and Pharmacology |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T18%3A03%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Adenosine%20and%20Adenosine%20Receptors%20in%20the%20Cardiovascular%20System:%20Biochemistry,%20Physiology,%20and%20Pharmacology&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=Shryock,%20John%20C&rft.date=1997-06-19&rft.volume=79&rft.issue=12&rft.spage=2&rft.epage=10&rft.pages=2-10&rft.issn=0002-9149&rft.eissn=1879-1913&rft.coden=AJCDAG&rft_id=info:doi/10.1016/S0002-9149(97)00256-7&rft_dat=%3Cproquest_cross%3E79130444%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c562t-db952a159c3420c2078110015d0c9ae9baa1ca441f1923045268d191f24fefe83%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1266084994&rft_id=info:pmid/9223356&rfr_iscdi=true |